Home The Word Brain My Amedeo FAQ Privacy About   


Explore this week’s CC Journal Club

90‑sec video • 4‑min audio • paper abstracts

This week, 27 April 2025:

  1. Treatment-resistant hypertension
  2. Influenza transmission
  3. Nanoplastics in human brains
  4. Malaria elimination
  5. Chikungunya vaccine

  Malignant Melanoma

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 20 articles:
HTML format



Single Articles


    March 2025
  1. GREINER D, Xue Q, Waddell TQ, Kurudza E, et al
    Human CSPG4-targeting CAR-macrophages inhibit melanoma growth.
    Oncogene. 2025 Mar 13. doi: 10.1038/s41388-025-03332.
    PubMed     Abstract available


    November 2024
  2. WHABY M, Ketavarapu G, Koide A, Mazzei M, et al
    Inhibition and degradation of NRAS with a pan-NRAS monobody.
    Oncogene. 2024;43:3489-3497.
    PubMed     Abstract available


    September 2024
  3. WORRALL C, Suleymanova N, Crudden C, Drakensjo IT, et al
    Correction: Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma.
    Oncogene. 2024 Sep 9. doi: 10.1038/s41388-024-03146.
    PubMed    


    April 2024
  4. REGER DE MOURA C, Louveau B, Jouenne F, Vilquin P, et al
    Inactivation of kindlin-3 increases human melanoma aggressiveness through the collagen-activated tyrosine kinase receptor DDR1.
    Oncogene. 2024 Apr 3. doi: 10.1038/s41388-024-03014.
    PubMed     Abstract available


    March 2024
  5. DURAND S, Tang Y, Pommier RM, Benboubker V, et al
    ZEB1 controls a lineage-specific transcriptional program essential for melanoma cell state transitions.
    Oncogene. 2024 Mar 22. doi: 10.1038/s41388-024-03010.
    PubMed     Abstract available


    February 2024
  6. XIAO Y, Zhou L, Andl T, Zhang Y, et al
    YAP1 controls the N-cadherin-mediated tumor-stroma interaction in melanoma progression.
    Oncogene. 2024 Feb 2. doi: 10.1038/s41388-024-02953.
    PubMed     Abstract available


  7. JESSEN M, Gertzmann D, Liss F, Zenk F, et al
    Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers.
    Oncogene. 2024;43:578-593.
    PubMed     Abstract available


    January 2024
  8. CANNON AC, Budagyan K, Uribe-Alvarez C, Kurimchak AM, et al
    Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints.
    Oncogene. 2024 Jan 19. doi: 10.1038/s41388-024-02947.
    PubMed     Abstract available


    December 2023
  9. HAN S, Zhang M, Qu X, Wu Z, et al
    SOX10 deficiency-mediated LAMB3 upregulation determines the invasiveness of MAPKi-resistant melanoma.
    Oncogene. 2023 Dec 15. doi: 10.1038/s41388-023-02917.
    PubMed     Abstract available


  10. JAGIRDAR K, Portuallo ME, Wei M, Wilhide M, et al
    ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma.
    Oncogene. 2023 Dec 8. doi: 10.1038/s41388-023-02900.
    PubMed     Abstract available


    November 2023
  11. KURTENBACH S, Sanchez MI, Kuznetsoff J, Rodriguez DA, et al
    PRAME induces genomic instability in uveal melanoma.
    Oncogene. 2023 Nov 29. doi: 10.1038/s41388-023-02887.
    PubMed     Abstract available


    September 2023
  12. LUO Y, Zhu Q, Xiang S, Wang Q, et al
    Downregulated circPOKE promotes breast cancer metastasis through activation of the USP10-Snail axis.
    Oncogene. 2023 Sep 16. doi: 10.1038/s41388-023-02823.
    PubMed     Abstract available


  13. RICHARDS JR, Shin D, Pryor R, Sorensen LK, et al
    Correction: Activation of NFAT by HGF and IGF-1 via ARF6 and its effector ASAP1 promotes uveal melanoma metastasis.
    Oncogene. 2023 Sep 8. doi: 10.1038/s41388-023-02828.
    PubMed    


  14. SHINZAWA K, Matsumoto S, Sada R, Harada A, et al
    GREB1 isoform 4 is specifically transcribed by MITF and required for melanoma proliferation.
    Oncogene. 2023 Sep 1. doi: 10.1038/s41388-023-02803.
    PubMed     Abstract available


    July 2023
  15. ARUMI-PLANAS M, Rodriguez-Baena FJ, Cabello-Torres F, Gracia F, et al
    Microenvironmental Snail1-induced immunosuppression promotes melanoma growth.
    Oncogene. 2023 Jul 29. doi: 10.1038/s41388-023-02793.
    PubMed     Abstract available


  16. RICHARDS JR, Shin D, Pryor R, Sorensen LK, et al
    Activation of NFAT by HGF and IGF-1 via ARF6 and its effector ASAP1 promotes uveal melanoma metastasis.
    Oncogene. 2023 Jul 27. doi: 10.1038/s41388-023-02792.
    PubMed     Abstract available


    June 2023
  17. LUO R, Chyr J, Wen J, Wang Y, et al
    A novel integrated approach to predicting cancer immunotherapy efficacy.
    Oncogene. 2023;42:1913-1925.
    PubMed     Abstract available


    March 2023
  18. MALVI P, Reddy DS, Kumar R, Chava S, et al
    LIMK2 promotes melanoma tumor growth and metastasis through G3BP1-ESM1 pathway-mediated apoptosis inhibition.
    Oncogene. 2023 Mar 16. doi: 10.1038/s41388-023-02658.
    PubMed     Abstract available


  19. KUSER-ABALI G, Zhang Y, Szeto P, Zhao P, et al
    UHRF1/UBE2L6/UBR4-mediated ubiquitination regulates EZH2 abundance and thereby melanocytic differentiation phenotypes in melanoma.
    Oncogene. 2023 Mar 11. doi: 10.1038/s41388-023-02631.
    PubMed     Abstract available


  20. DING Y, Chen J, Li S, Wren JD, et al
    EWI2 and its relatives in Tetraspanin-enriched membrane domains regulate malignancy.
    Oncogene. 2023;42:861-868.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.